Dublin, Feb. 10, 2020 (GLOBE NEWSWIRE) -- The "Apheresis Market by Product [Device (Centrifugation, Membrane Separation) Disposable], Procedure (Donor, Therapeutic ...
Lipoprotein apheresis involves the extracorporeal removal of LDL and lipoprotein(a) particles from whole blood or plasma by adsorption, precipitation or differential filtration. Used repetitively, ...
In recent years, as many of the diseases for which allogeneic HPC transplantation is indicated are associated with advancing age; this therapy has been increasingly offered to patients in their sixth ...
The Plasmapheresis Market has been gaining notable momentum in the global healthcare sector due to the rising prevalence of ...
Significant advances have been made over the last 20 years in long-term immunomodulatory therapy of multiple sclerosis. However, the same cannot be said for the treatment of acute relapses, explain ...
Zacks Investment Research on MSN
IBRX stock jumps on progress in NK cell therapy production
Shares of ImmunityBio IBRX rose more than 7% on Friday after the company announced that it completed two manufacturing ...
The global ApheresisMarket features a highly competitive vendor landscape, with few large vendors holding massive share in the overall market, observes Transparency Market Research. The high costs ...
The global apheresis market is expected to grow at a CAGR of ~8% during the forecast period. The market expansion is driven by the increasing prevalence of chronic and autoimmune diseases, growing ...
Rome, Italy – 29 August, 2016: Lipoprotein apheresis, a therapy normally used to filter excess cholesterol from the blood of patients with familial hypercholesterolemia, may have a new role in ...
Subhash Banerjee, MD (VA North Texas Health Care System & UT Southwestern Medical Center, Dallas), who presented the results of the PREMIER trial in a featured clinical research session at the annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results